This study employed both single variant and whole gene-based approaches to assess the burden of deleterious variants ERAP1 and ERAP2 in the UK Biobank and a local cohort of IBD patients with WES and deep clinical phenotype data. This evidence concerns the gene ERAP2 and inflammatory bowel disease.